Our study was not designed to assess accelerated or accentuated neurodegeneration in PLWH, but if it takes place, these processes seem to lead to tau and amyloid protein aggregation processes that are different in magnitude, and have different mechanisms, from those detected by validated combinations of CSF biomarkers for AD. This evidence concerns the gene MAPT and Alzheimer disease.